Researchers from the Institute for Glycomics and the University of Adelaide, have entered into an exclusive licensing deal withSienna Cancer...
The mystery surrounding the targeted removal of red blood cells from the human body is at the centre of new Griffith University research.
Professor Paul Clarke will join the University as the inaugural Executive Director of the new Institute for Biomedicine and Glycomics.
Native Charge Detection Mass Spectrometry will enable cross-collaboration research to develop life-changing therapies, vaccines and diagnostics.
We’re excited to announce the launch of the Bourne Foundation Nuclear Magnetic Resonance (NMR) Facility, an institute core facility that...
The first week of October brought with it a flurry of activity at Griffith University’s Institute for Glycomics as they...
Cutting-edge research and transformative applications achieves real-world impact.
Researchers identify how vector-borne diseases in different environments respond to human pressures.
Scientific dreams could become reality for creative Griffith nanotechnology researcher.
The ability to identify unique sugars that decorate ovarian cancer cells could help prevent the spread of cancer and improve treatment options for women.
